Z-DNA binding proteins as targets for structure-based virtual screening.

Area of Science:

• Molecular Biology
• Immunology
• Drug Discovery

Background:

• Z-DNA is an alternative DNA structure involved in nucleotide metabolism.
• Vertebrate Z-DNA binding proteins (ZBPs), such as ADAR1, DAI, and PKZ, regulate innate immunity, particularly interferon-induced responses.
• Viral proteins, like vaccinia virus E3L, can interfere with host ZBPs to suppress immune responses.

Purpose of the Study:

• To provide an overview of Z-DNA and ZBPs as potential therapeutic targets.
• To summarize recent advancements in the structure-based discovery of ZBP inhibitors.

Main Methods:

• Review of existing literature on Z-DNA, ZBPs, and their roles in immunity.
• Analysis of recent progress in computer-aided drug development for ZBP inhibitors.
• Examination of high-resolution structural data (crystal and NMR) of ZBPs.

Main Results:

• ZBPs are critical regulators of innate immunity and are targeted by viral pathogens.
• The structural information of ZBPs facilitates the discovery of novel inhibitors.
• Computer-aided drug development approaches are advancing the identification of ZBP inhibitors.

Conclusions:

• ZBPs represent attractive therapeutic targets for infectious and immune diseases.
• Structure-based drug design is a promising strategy for developing ZBP inhibitors.
• Further research in this area could lead to new treatments for various diseases.